Epigenetic Consequences of in Utero Exposure to Rosuvastatin Alteration of Histone Methylation Patterns in Newborn Rat Brains /

Rosuvastatin (RST) is primarily used to treat high cholesterol levels. As it has potentially harmful but not well-documented effects on embryos, RST is contraindicated during pregnancy. To demonstrate whether RST could induce molecular epigenetic events in the brains of newborn rats, pregnant mother...

Full description

Saved in:
Bibliographic Details
Main Authors: Dulka Karolina
Szabó Melinda
Biróné Lajkó Noémi
Belecz István
Hoyk Zsófia
Gulya Károly
Format: Article
Published: 2021
Series:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22 No. 7
Subjects:
doi:10.3390/ijms22073412

mtmt:31997620
Online Access:http://publicatio.bibl.u-szeged.hu/22471
LEADER 02627nab a2200289 i 4500
001 publ22471
005 20210924120326.0
008 210924s2021 hu o 0|| Angol d
022 |a 1661-6596 
024 7 |a 10.3390/ijms22073412  |2 doi 
024 7 |a 31997620  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a Angol 
100 1 |a Dulka Karolina 
245 1 0 |a Epigenetic Consequences of in Utero Exposure to Rosuvastatin  |h [elektronikus dokumentum] :  |b Alteration of Histone Methylation Patterns in Newborn Rat Brains /  |c  Dulka Karolina 
260 |c 2021 
300 |a Terjedelem: 17 p-Azonosító: 3412 
490 0 |a INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES  |v 22 No. 7 
520 3 |a Rosuvastatin (RST) is primarily used to treat high cholesterol levels. As it has potentially harmful but not well-documented effects on embryos, RST is contraindicated during pregnancy. To demonstrate whether RST could induce molecular epigenetic events in the brains of newborn rats, pregnant mothers were treated daily with oral RST from the 11th day of pregnancy for 10 days (or until delivery). On postnatal day 1, the brains of the control and RST-treated rats were removed for Western blot or immunohistochemical analyses. Several antibodies that recognize different methylation sites for H2A, H2B, H3, and H4 histones were quantified. Analyses of cell-type-specific markers in the newborn brains demonstrated that prenatal RST administration did not affect the composition and cell type ratios as compared to the controls. Prenatal RST administration did, however, induce a general, nonsignificant increase in H2AK118me1, H2BK5me1, H3, H3K9me3, H3K27me3, H3K36me2, H4, H4K20me2, and H4K20me3 levels, compared to the controls. Moreover, significant changes were detected in the number of H3K4me1 and H3K4me3 sites (134.3% +/- 19.2% and 127.8% +/- 8.5% of the controls, respectively), which are generally recognized as transcriptional activators. Fluorescent/confocal immunohistochemistry for cell-type-specific markers and histone methylation marks on tissue sections indicated that most of the increase at these sites belonged to neuronal cell nuclei. Thus, prenatal RST treatment induces epigenetic changes that could affect neuronal differentiation and development. 
650 4 |a Biológiai tudományok 
650 4 |a Általános orvostudomány 
700 0 1 |a Szabó Melinda  |e aut 
700 0 2 |a Biróné Lajkó Noémi  |e aut 
700 0 2 |a Belecz István  |e aut 
700 0 2 |a Hoyk Zsófia  |e aut 
700 0 2 |a Gulya Károly  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/22471/1/ijms-22-03412-1.pdf  |z Dokumentum-elérés